Category(s): Stem Cell Therapy
Doug Melton, who led the work for treatment of diabetes with stem cells from the Harvard Institute and who 23 years ago, when his then infant son Sam was diagnosed with type 1 diabetes, dedicated his career to finding a cure for the disease, said he hopes to have human transplantation trials using the cells to be underway within a few years.
“We are now just one pre-clinical step away from the finish line,” said Melton in October of 2014, whose daughter Emma also has type 1 diabetes.
The generation of insulin-producing pancreatic cells from stem cells in-vitro would provide an unprecedented cell source for drug discovery and cell transplantation therapy in diabetes.
Elaine Fuchs, the Rebecca C. Lancefield Professor at Rockefeller University, and a Howard Hughes Medical Institute Investigator who is not involved in the work, hailed it as “one of the most important advances to date in the stem cell field, and I join the many people throughout the world in applauding my colleague for this remarkable achievement.